Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

ZURA US Equity

Zura Bio LtdHealth Care · Biological Products, (No Diagnostic Substances) · CIK 1855644 · FY ends Dec 31
$5.84
+0.07 (+1.21%)
USD · as of 2026-08-19 · marketstack

Short interest· FINRA consolidated · settlement 2026-07-31

6 settlement cycles
Shares short10.5M
% of shares out11.0%
Days to cover19.6
Δ vs 2026-07-15+2.5%
▲ 10.5M shares shortline top = 19.6d to cover2026-05-15: 6.2M short · 9.2d to cover2026-052026-05-29: 6.2M short · 9.1d to cover2026-052026-06-15: 5.9M short · 5.4d to cover2026-062026-06-30: 9.2M short · 4.0d to cover2026-062026-07-15: 10.3M short · 9.5d to cover2026-072026-07-31: 10.5M short · 19.6d to cover2026-07

bars = shares short · line = days to cover (own scale)

SettlementShares shortΔ vs priorAvg daily volumeDays to cover
2026-07-3110,513,220+2.5%536,90219.6
2026-07-1510,252,606+10.9%1,076,4379.5
2026-06-309,242,718+57.4%2,279,4374.0
2026-06-155,873,622-5.6%1,089,2555.4
2026-05-296,219,823-0.3%685,3619.1
2026-05-156,241,113-10.5%675,7299.2

FINRA Rule 4560 · twice monthly, published ~a week later.

Output of a disclosed model — assumptions may be wrong. Research, not investment advice. See the Disclaimer.